Overview
Neuromodulation and brain-computer interface medical device developer.
Funding
USD estimates from the source recordListed 2 funding records. Latest funding: $29M (B+), Jun 18, 2026.
Annual trendUnit: USD estimate
| Date | Amount | Investors | Source |
|---|---|---|---|
| Jun 18, 2026 | $29M | Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), Zhongjin Capital | |
| Feb 7, 2026 | $25M | Saiying Capital |
Valuation
USD estimates from the source recordListed 2 valuation records.
Annual trendUnit: USD estimate
No chartable valuation estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Source |
|---|---|---|---|
| Jun 18, 2026 | — | Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), Zhongjin Capital | |
| Feb 7, 2026 | — | Saiying Capital |
Revenue
USD estimates from the source recordNo revenue records are listed yet.
Annual trendUnit: USD estimate
No chartable revenue estimates yet.
No revenue rows to list.
Team, products & investors
Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
神经调控及脑机接口医疗器械研发商